Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

7792 ARTÍCULOS , VIENDO DEL 1936 AL 1950

Effects of aerobic and resistance training on walking and balance abilities in older adults with Parkinson's disease: A systematic review and meta-analysis

Song H, Ge S, Li J, Jiao C, Ran L.

PLoS One. 2025 Jan 9;20(1):e0314539. doi: 10.1371/journal.pone.0314539. eCollection 2025.

Brain aging and rejuvenation at single-cell resolution

Sun ED, Nagvekar R, Pogson AN, Brunet A.

Neuron. 2025 Jan 8;113(1):82-108. doi: 10.1016/j.neuron.2024.12.007.

Research hotspots and trends in the antioxidant effects of acupuncture: A bibliometric analysis from 2003 to 2024

Huang Z, Li S, Zhou Y, Dai A, Zhang Y, Liu M, Le M, Shi J.

Complement Ther Med. 2025 Mar;88:103123. doi: 10.1016/j.ctim.2024.103123. Epub 2025 Jan 7.

Advancing neurological disorders therapies: Organic nanoparticles as a key to blood-brain barrier penetration

Sadat Razavi Z, Sina Alizadeh S, Sadat Razavi F, Souri M, Soltani M.

Int J Pharm. 2025 Feb 10;670:125186. doi: 10.1016/j.ijpharm.2025.125186. Epub 2025 Jan 7.

WITHDRAWN: Biomarker Detection and Therapy of Parkinson's and Alzheimer's disease using upconversion based approach: A Comprehensive Review

Ghorpade KB, Agrawal S, Havelikar U.

Ageing Res Rev. 2025 Jan 7:102656. doi: 10.1016/j.arr.2025.102656. Online ahead of print.

Targeting pathological brain activity-related to neuroinflammation through scRNA-seq for new personalized therapies in Parkinson's disease

Mirzac D, Bange M, Kunz S, de Jager PL, Groppa S, Gonzalez-Escamilla G.

Signal Transduct Target Ther. 2025 Jan 10;10(1):10. doi: 10.1038/s41392-024-02086-7.

Late-onset CSF1R-related Disorder: A Case Report

Chen L, Xu H, Lu Z.

Cogn Behav Neurol. 2025 Mar 1;38(1):16-20. doi: 10.1097/WNN.0000000000000385.

Managing sleep issues in Parkinson's disease: an up-to-date review

Suzuki K, Fujita H, Kobayashi S.

Expert Rev Neurother. 2025 Feb;25(2):211-226. doi: 10.1080/14737175.2025.2450789. Epub 2025 Jan 10.

Opicapone as adjunct to levodopa in treated Parkinson's disease without motor complications: A randomized clinical trial

Ferreira JJ, Rascol O, Stocchi F, Antonini A, Moreira J, Castilla-Fernández G, Rocha JF, Holenz J, Poewe W; Epsilon Study investigators.

Eur J Neurol. 2025 Jan;32(1):e16420. doi: 10.1111/ene.16420.

Parkinson's Disease and Caregiving Roles, Demands, and Support Needs and Experiences: A Scoping Review

Longacre ML, Roche L, Kueppers GC, Buurman B.

Healthcare (Basel). 2025 Jan 4;13(1):79. doi: 10.3390/healthcare13010079.

Amyotrophic Lateral Sclerosis and Parkinson's Disease: Brain Tissue Transcriptome Analysis Reveals Interactions

Fu Z, Feng B, Akogo HY, Ma J, Liu Y, Quan H, Zhang X, Hou Y, Zhang X, Ma J, Cui H.

Mol Neurobiol. 2025 May;62(5):6383-6396. doi: 10.1007/s12035-024-04681-9. Epub 2025 Jan 10.

Topical review: Ocular surface abnormalities in neurodegenerative disorders

Waller SE, Stockwell JB, Fung VSC, Anstey KJ, Colebatch JG, Markoulli M, Krishnan AV.

Optom Vis Sci. 2025 Feb 1;102(2):68-77. doi: 10.1097/OPX.0000000000002215. Epub 2025 Jan 9.

Exploring tele-speech therapy: A scoping review of interventions, applications, benefits, and challenges

Moulaei K, Dinari F, Hosseini M, Almasi S, Sabet B, Anabestani R, Afrash MR.

Int J Med Inform. 2025 Mar;195:105784. doi: 10.1016/j.ijmedinf.2025.105784. Epub 2025 Jan 8.

A systematic review of diffusion tensor imaging and tractography in dementia with Lewy bodies and Parkinson's disease dementia

Laurell AAS, Mak E, O'Brien JT.

Neurosci Biobehav Rev. 2025 Feb;169:106007. doi: 10.1016/j.neubiorev.2025.106007. Epub 2025 Jan 9.

Current trends in blood biomarkers detection and neuroimaging for Parkinson's disease

Liu N, Zhang T, Zhao W, Zhao X, Xue Y, Deng Q.

Ageing Res Rev. 2025 Feb;104:102658. doi: 10.1016/j.arr.2025.102658. Epub 2025 Jan 9.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias